Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: Molecular basis, clinical risk factors, and outcome

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 420-427

  Sánchez Romero, Isabel ^a   Asensio, Ángel ^a   Oteo, Jesús ^b   Muñoz Algarra, María ^a   Isidoro, Beatriz ^a   Vindel, Ana ^b   Álvarez Avello, José ^a   Balandín Moreno, Bárbara ^a   Cuevas, Oscar ^b   Fernández Romero, Sara ^b   Azañedo, Luisa ^b   Sáez, David ^b   Campos, José ^b,c  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; CATHETER ASSOCIATED BACTEREMIA; CATHETER INFECTION; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; DNA FINGERPRINTING; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; RISK FACTORS; SPAIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84455192532     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05036-11     Document Type: Article

References (39)

1. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML. 2000. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am. J. Med. 108:609-613. (Pubitemid 30336599)
2. Cagnacci S, et al. 2008. Bloodstream infections caused by multidrugresistant Klebsiella pneumoniae producing the carbapenem hydrolysing VIM-1 metallo-β-lactamase: first Italian outbreak. J. Antimicrob. Chemother. 61:296-300.
3. Carattoli A, et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
4. Carattoli A, et al. 2006. Replicon typing of plasmids encoding resistance to newer β-lactams. Emerg. Infect. Dis. 12:1145-1148. (Pubitemid 44061290)
5. Carmeli Y, et al. 2010. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin. Microbiol. Infect. 16:102-111.
6. Cendejas E, Gómez-Gil R, Gómez-Sánchez P, Mingorance J. 2010. Detection and characterization of Enterobacteriaceae producing metallo- β-lactamases in a tertiary-care hospital in Spain. Clin. Microbiol. Infect. 16:181-183.
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. (Pubitemid 17055592)
8. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing, 20th informational supplement, M100-S20, vol. 30, no. 1. Clinical and laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing, 20th informational supplement, M100-S21, vol. 31, no. 1. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Cornaglia G, et al. 2007. Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues. Int. J. Antimicrob. Agents 29:380-388. (Pubitemid 46349587)
11. Crowder MW, Spencer J, Vila AJ. 2006. Metallo-β-lactamases: novel weaponry for antibiotic resistance in bacteria. Acc. Chem. Res. 39:721-728.
12. Damjanova I, et al. 2008. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type β-lactamase- producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 - the new "MRSAs"? J. Antimicrob. Chemother. 68:978-985.
13. ESBLsurrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae. J. Antimicrob. Chemother. 63:60-66.
14. European Committee on Antimicrobial Susceptibility Testing. 2011. Clinical breakpoints. European Committee on Antimicrobial Susceptibility Testing, Växjö, Sweden. http://www.eucast.org/clinical-breakpoints/. Last accessed 15 January 2011.
15. Falcone, M., et al. 2009. Infections with VIM-1 metallo-β- lactamaseproducing Enterobacter cloacae and their correlation with clinical outcome. J. Clin. Microbiol. 47:3514-3519.
16. Fritsche TR, Castanheira M, Miller GH, Jones RN, Armstrong ES. 2008. Detection of methyltransferases conferring high-level resistance to aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America. Antimicrob. Agents Chemother. 52:1843-1845. (Pubitemid 351614683)
17. CTX-M-9 gene by R478-IncHI2 derivative plasmids. FEMS Microbiol. Lett. 271:71-77.
18. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. 1988. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 16:128-140.
19. Giakoupi P, et al. 2009. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill. 14(21):pii=19218. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 19218.
20. Grundmann H, et al. 2010. Carbapenem-nonsusceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 15(46):pii=19711. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 19711.
21. ACT-1 beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe. Antimicrob. Agents Chemother. 50:3396-3406.
22. Kassis-Chikhani N, et al. 2010. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004. Euro Surveill. 15(46):pii=19713. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19713.
23. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. 1985. APACHE II: a severity of disease classification system. Crit. Care Med. 13:818-829. (Pubitemid 15250137)
24. Laurent C, et al. 2008. Intensive care unit outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect. Control Hosp. Epidemiol. 29:517-524. (Pubitemid 351918030)
25. Miriagou V, et al. 2010. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect. 16:112-122.
26. CTX-M genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. J. Antimicrob. Chemother. 65:661- 665.
27. Munoz-Price LS, et al. 2010. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect. Control Hosp. Epidemiol. 31:1074-1077.
28. Nadkarni AS, Schliep T, Khan L, Zeana CB. 2009. Cluster of blood-stream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Am. J. Infect. Control 37:121-126.
29. Navon-Venezia S, et al. 2009. First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob. Agents Chemother. 53:818-820.
30. Nielsen JB, Skov MN, RLJørgensen Heltberg O, Hansen DS, Schønning K. 2011. Identification of CTX-M-15-, SHV-28-producing Klebsiella pneumoniae ST15 as an epidemic clone in the Copenhagen area using a semi-automated Rep-PCR typing assay. Eur. J. Clin. Microbiol. Infect. Dis. 30:773-778.
31. Oteo J, et al. 2008. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int. J. Antimicrob. Agents 32:534 -537.
32. Oteo J, et al. 2010. Outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr. Infect. Dis. J. 29:1144 -1146.
33. VIM-1- positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J. Antimicrob. Chemother. 61:59-63.
34. Rossolini GM, Mantengoli E, Docquier JD, Musmanno RA, Coratza G. 2007. Epidemiology of infections caused by multiresistant gramnegatives: ESBLs, MBLs, panresistant strains. New Microbiol. 30:332-339. (Pubitemid 47264901)
35. Sunde M. 2005. Prevalence and characterization of class 1 and class 2 integrons in Escherichia coli isolated from meat and meat products of Norwegian origin. J. Antimicrob. Chemother. 56:1019-1024. (Pubitemid 43009814)
36. Tato M, et al. 2007. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-β- lactamase in Spain: toward endemicity? Clin. Infect. Dis. 45:1171-1178. (Pubitemid 47580315)
37. Treviño M, Moldes L, Martínez-Lamas L, Varón C, Regueiro BJ. 2009. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-β-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain) Eur. J. Clin. Microbiol. Infect. Dis. 28:1253-1258.
38. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. Metallo-β- lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
39. Yildirim I, Ceyhan M, Gur D, Mugnaioli C, Rossolini GM. 2007. First detection of VIM-1 type metallo-β-lactamase in a multidrug-resistant Klebsiella pneumoniae clinical isolate from Turkey also producing the CTX-M-15 extended-spectrum β-lactamase. J. Chemother. 19:467- 468.